Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boulder/denver blog main
boulder/denver top stories
cancer
5
×
detroit blog main
detroit top stories
europe blog main
europe top stories
5
×
indiana blog main
5
×
indiana top stories
life sciences
national
national blog main
national top stories
5
×
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
startups
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
alzheimer's disease
boston top stories
fda
abbvie
biogen
clinical trials
covid-19
deals
eli lilly
gilead sciences
What
bio
roundup
5
×
acquisitions
buy
ceo
covid
daniel
debut
gilead
ipo
medicines
moves
o’day
sciences
week
activity
alliance
announced
approvals
biggest
biogen
black
bristol
build
calls
changing
clamped
collabs
color
companies
company’s
continue
crispr
days
deal
delays
developing
diamond
diamond’s
drug
Language
unset
5
×
Current search:
roundup
×
cancer
×
unset
×
" national top stories "
×
" indiana blog main "
×
" europe top stories "
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
4 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More